Non-Invasive Skin Imaging of Pseudoxanthoma Elasticum Using Dynamic Optical Coherence Tomography: Insights from a Case-Control Study

Non-Invasive Skin Imaging of Pseudoxanthoma Elasticum Using Dynamic Optical Coherence Tomography: Insights from a Case-Control Study

Authors

Keywords:

pseudoxanthoma elasticum, Optical Coherence Tomography, elastic tissue, skin, non‐invasive skin imaging, rare disease

Abstract

Introduction: Pseudoxanthoma elasticum (PXE) is a rare genetic disorder characterized by progressive mineralization and fragmentation of elastic fibers, leading to multisystem involvement. Diagnosis relies on clinical features, histopathology, and, in selected cases, genetic testing, with cutaneous manifestations often representing the earliest signs.

Objective: To validate dynamic optical coherence tomography (D-OCT) as a noninvasive diagnostic method for detecting PXE-related dermal abnormalities.

Methods: In this case-control study, PXE patients evaluated at Umberto I Policlinic (Rome, Italy) between May 2023 and September 2024 underwent clinical and instrumental assessment. The left lateral cervical, retrocervical, left axillary, and periumbilical folds were analyzed using a standardized 0–3 clinical severity scale and D-OCT imaging. Control subjects were individuals undergoing routine mole checks. D-OCT quantified fiber density, attenuation, and vessel density at 300 µm and 500 µm depths. Statistical analysis included Spearman’s correlation and the Mann-Whitney U test, with p < 0.05 considered significant.

Results: Twenty-three PXE patients and eleven controls were included. Cutaneous involvement was observed in 91.30% of patients, predominantly in retrocervical (86.95%) and lateral cervical (82.60%) areas. Clinical severity significantly correlated with D-OCT fiber density in the retrocervical region (ρ = 0.507). Compared with controls, PXE patients showed reduced fiber density and increased attenuation across most regions, except the axillae. At 500 µm depth, vessel density was markedly decreased in the axillary area, with approximately 2.5-fold fewer vessels in PXE skin.

Conclusion: D-OCT effectively detects dermal alterations in PXE, including subclinical changes, providing a promising noninvasive alternative to skin biopsy.

References

Verschuere S, Navassiolava N, Martin L, Nevalainen PI, Coucke PJ, Vanakker OM. Reassessment of causality of ABCC6 missense variants associated with pseudoxanthoma elasticum based on Sherloc. Genet Med. 2021 Jan;23(1):131–9. DOI: 10.1038/s41436-020-00945-6. PMID: 32873932.

Verschuere S, Van Gils M, Nollet L, Vanakker OM. From membrane to mineralization: the curious case of the ABCC6 transporter. FEBS Lett. 2020 Dec;594(23):4109–33. DOI: 10.1002/1873-3468.13981. PMID: 33131056.

Bisaccia F, Koshal P, Abruzzese V, Castiglione Morelli MA, Ostuni A. Structural and functional characterization of the abcc6 transporter in hepatic cells: Role on pxe, cancer therapy and drug resistance. Int J Mol Sci. 2021;22(6):1–12. PMID: 33799762.

Germain DP. Pseudoxanthoma elasticum. Orphanet J Rare Dis. 2017 May;12(1). DOI: 10.1186/S13023-017-0639-8. PMID: 28486967.

Plomp AS, Toonstra J, Bergen AAB, Van Dijk MR, De Jong PTVM. Proposal for updating the pseudoxanthoma elasticum classification system and a review of the clinical findings. Am J Med Genet A. 2010 Apr;152(4):1049–58. DOI: 10.1002/ajmg.a.33329. PMID: 20358627.

Laghi A, Mandel VD, Zubba I, Franceschini C, Demofonte I, Chello C, et al. Comprehensive analysis of pseudoxanthoma elasticum: epidemiological, genetic, and clinical findings from the leading Italian center. Italian journal of dermatology and venereology. 2024 Aug;159(4):430–5. DOI: 10.23736/S2784-8671.24.07949-0. PMID: 39069841.

Neidner KH. Pseudoxanthoma elasticum. Clin Dermatol. 1988;6(1):1–4. DOI: 10.1016/0738-081x(88)90003-x. PMID: 3359381.

Persechino F, Giordano D, Marini CD, Franceschini C, Ardigò M, Persechino S. Dermoscopy, Optical Coherence Tomography, and Histological Correlation of Pseudoxanthoma Elasticum. Dermatol Pract Concept. 2019 Jul;9(3):209–10. DOI: 10.5826/dpc.0903a07. PMID: 31384495.

Mehrabi JN, Doong J, Lentsch G, Mesinkovska N. Imaging of vivo pseudoxanthoma elasticum via multiphoton microscopy and optical coherence tomography. JAAD Case Rep. 2020 Aug;6(8):702–4. DOI: 10.1016/j.jdcr.2020.05.029. PMID: 32715054.

Csuka EA, Ward SC, Ekelem C, Csuka DA, Ardigò M, Mesinkovska NA. Reflectance Confocal Microscopy, Optical Coherence Tomography, and Multiphoton Microscopy in Inflammatory Skin Disease Diagnosis. Lasers Surg Med. 2021 Aug;53(6):776–97. DOI: 10.1002/lsm.23386. PMID: 33527483.

Schuh S, Holmes J, Ulrich M, Themstrup L, Jemec GBE, De Carvalho N, et al. Imaging Blood Vessel Morphology in Skin: Dynamic Optical Coherence Tomography as a Novel Potential Diagnostic Tool in Dermatology. Dermatol Ther (Heidelb). 2017 Jun;7(2):187–202. DOI: 10.1007/s13555-017-0175-4. PMID: 28258554.

Lindsø Andersen P, Olsen J, Friis KBE, Themstrup L, Grandahl K, Mortensen OS, et al. Vascular morphology in normal skin studied with dynamic optical coherence tomography. Exp Dermatol. 2018 Sep;27(9):966–72. DOI: 10.1111/exd.13680. PMID: 29733465.

VivoSight brochure [Internet]. [cited 2025 Jan 1]. Available from: https://vivosight.com/wp-content/uploads/2023/03/VivoSight-brochure_2023.pdf

Bentov I, Reed MJ. The effect of aging on the cutaneous microvasculature. Microvasc Res. 2015 Jul;100:25–31. DOI: 10.1016/j.mvr.2015.04.004. PMID: 25917013.

Published

2025-10-31

How to Cite

1.
Chello C, Laghi A, Melchiorri L, et al. Non-Invasive Skin Imaging of Pseudoxanthoma Elasticum Using Dynamic Optical Coherence Tomography: Insights from a Case-Control Study. Dermatol Pract Concept. 2025;15(4):5260. doi:10.5826/dpc.1503a5260

Share